<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  
  <title>Baricitinib 💊 | iClass eXpert</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  
  <meta name="keywords" content="Chemical" />
  
  
  
  
  <meta name="description" content="Baricitinib, sold under the brand name Olumiant among others, is a medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an inhibitor of janus kinase (JA">
<meta property="og:type" content="article">
<meta property="og:title" content="Baricitinib 💊">
<meta property="og:url" content="https://iclass.cc/2023/01/02/2023-01-02-00-19-baricitinib/index.html">
<meta property="og:site_name" content="iClass eXpert">
<meta property="og:description" content="Baricitinib, sold under the brand name Olumiant among others, is a medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an inhibitor of janus kinase (JA">
<meta property="og:locale" content="en_US">
<meta property="og:image" content="https://iclass.cc/2023/01/02/2023-01-02-00-19-baricitinib/b1.png">
<meta property="og:image" content="https://iclass.cc/2023/01/02/2023-01-02-00-19-baricitinib/b2.svg">
<meta property="article:published_time" content="2023-01-02T00:19:00.000Z">
<meta property="article:modified_time" content="2024-03-01T03:47:35.262Z">
<meta property="article:author" content="Bruce">
<meta property="article:tag" content="Chemical">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="https://iclass.cc/2023/01/02/2023-01-02-00-19-baricitinib/b1.png">
  
    <link rel="alternate" href="/atom.xml" title="iClass eXpert" type="application/atom+xml">
  
  <link rel="icon" href="/css/images/favicon.ico">
  
    <link href="//fonts.googleapis.com/css?family=Source+Code+Pro" rel="stylesheet" type="text/css">
  
  <link href="https://fonts.googleapis.com/css?family=Open+Sans|Montserrat:700" rel="stylesheet" type="text/css">
  <link href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic" rel="stylesheet" type="text/css">
  <link href="//cdn.bootcss.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet">
  <style type="text/css">
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/9749f0/00000000000000000001008f/27/l?subset_id=2&fvd=n5) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/90cf9f/000000000000000000010091/27/l?subset_id=2&fvd=n7) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/8a5494/000000000000000000013365/27/l?subset_id=2&fvd=n4) format("woff2");font-weight:lighter;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/d337d8/000000000000000000010095/27/l?subset_id=2&fvd=i4) format("woff2");font-weight:400;font-style:italic;}</style>
    
  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Yanone+Kaffeesatz%3A200%2C300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">

  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Oswald%3A300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">
  
<link rel="stylesheet" href="/css/style.css">


  
<script src="/js/jquery-3.1.1.min.js"></script>


  <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="/css/bootstrap.css" >
  <link rel="stylesheet" href="/css/fashion.css" >
  <link rel="stylesheet" href="/css/glyphs.css" >

<meta name="generator" content="Hexo 6.2.0"></head>



  <body data-spy="scroll" data-target="#toc" data-offset="50">


  


<header id="allheader" class="site-header" role="banner" 
   >
  <div class="clearfix container">
      <div class="site-branding">

          <h1 class="site-title">
            
              <a href="/" title="iClass eXpert" rel="home"> iClass eXpert </a>
            
          </h1>
          
          
            <div class="site-description">A knowledge learning platform with English as the primary language</div>
          
            
          <nav id="main-navigation" class="main-navigation" role="navigation">
            <a class="nav-open">Menu</a>
            <a class="nav-close">Close</a>

            <div class="clearfix sf-menu">
              <ul id="main-nav" class="menu sf-js-enabled sf-arrows"  style="touch-action: pan-y;">
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663" linktext="/"> <a class="" href="/">Home</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663" linktext="archives"> <a class="" href="/archives">Archives</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663" linktext="categories"> <a class="" href="/categories">Categories</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663" linktext="tags"> <a class="" href="/tags">Tags</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663" linktext="about"> <a class="" href="/about">About</a> </li>
                    
              </ul>
            </div>
          </nav>

      </div>
  </div>
</header>


  <div id="container">
    <div id="wrap">
            
      <div id="content" class="outer">
        
          <section id="main" style="float:none;"><article id="post-2023-01-02-00-19-baricitinib" style="width: 66%; float:left;" class="article article-type-post" itemscope itemprop="blogPost" >
  <div id="articleInner" class="clearfix post-1016 post type-post status-publish format-standard has-post-thumbnail hentry category-template-2 category-uncategorized tag-codex tag-edge-case tag-featured-image tag-image tag-template">
    
    
      <header class="article-header">
        
  
    <h1 class="thumb" class="article-title" itemprop="name">
      Baricitinib 💊
    </h1>
  

      </header>
    
    <div class="article-meta">
      
	<a href="/2023/01/02/2023-01-02-00-19-baricitinib/" class="article-date">
	  <time datetime="2023-01-02T00:19:00.000Z" itemprop="datePublished">January 2, 2023</time>
	</a>

       
      
    </div>
    <div class="article-entry" itemprop="articleBody">
      
        <p><strong>Baricitinib</strong>, sold under the brand name Olumiant among others, is a medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Janus_kinase_inhibitor">inhibitor of janus kinase</a> (JAK), blocking the subtypes <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/JAK1">JAK1</a> and <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/JAK2">JAK2</a>.</p>
<p>Baricitinib is approved for medical use in the European Union and in the United States. An important side effect of JAK inhibitors is serious bacterial, mycobacterial, fungal and viral infections.</p>
<span id="more"></span>

<img src="/2023/01/02/2023-01-02-00-19-baricitinib/b1.png" width="222" align="right">

<h3 id="Mechanism-of-action"><a href="#Mechanism-of-action" class="headerlink" title="Mechanism of action"></a>Mechanism of action</h3><p><strong>Baricitinib</strong> is a Janus kinase (JAK) inhibitor that reversibly inhibits <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Janus_kinase_1">Janus kinase 1</a> with <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Half_maximal_inhibitory_concentration">a half maximal inhibitory concentration</a> (IC<sub>50</sub>) of 5.9 nM and <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Janus_kinase_2">Janus kinase 2</a> with an IC<sub>50</sub> of 5.7 nM. Tyrosine kinase 2, which belongs to the same enzyme family, is affected less (IC<sub>50</sub> &#x3D; 53 nM), and <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Janus_kinase_3">Janus kinase 3</a> far less (IC<sub>50</sub> &gt; 400 nM). Via a <a href="/2023/01/02/2023-01-02-00-19-baricitinib/transduction.svg">signal transduction</a> pathway involving <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/STAT_protein">STAT proteins</a>, this ultimately modulates gene expression in immunological cells. Other JAK inhibitors include <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Tofacitinib">tofacitinib</a>, which is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis; <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Fedratinib">fedratinib</a>, and <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Ruxolitinib">ruxolitinib</a>.</p>
<h3 id="Pharmacokinetics"><a href="#Pharmacokinetics" class="headerlink" title="Pharmacokinetics"></a>Pharmacokinetics</h3><p>The substance is quickly absorbed from the gut with an absolute bioavailability of 79%. It reaches highest blood plasma levels after about an hour; in different individuals the time to reach this level ranges from 0.5 to 3 hours. Food intake has no relevant influence on the drug’s pharmacokinetics. 50% of the circulating baricitinib are bound to blood plasma proteins. Less than 10% of the substance is metabolized to four different oxidation products by CYP3A4; the rest is left unchanged. <a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Elimination_half-life">Elimination half-life</a> is 12.5 hours on average. About 75% is eliminated via the urine, and 20% via the faeces.</p>
<h3 id="Side-effects"><a href="#Side-effects" class="headerlink" title="Side effects"></a>Side effects</h3><p>In studies, upper respiratory tract infections and high blood cholesterol levels (hypercholesterolemia) occurred in more than 10% of patients. Less common side effects included other infections such as herpes zoster, herpes simplex, urinary tract infections, and gastroenteritis.</p>
<img src="/2023/01/02/2023-01-02-00-19-baricitinib/b2.svg" width="222" align="right">

<h3 id="効能"><a href="#効能" class="headerlink" title="効能"></a>効能</h3><ul>
<li>既存治療で効果不十分な関節リウマチ(関節の構造的損傷の防止を含む)</li>
<li>アトピー性皮膚炎(最適使用推進ガイドライン対象)</li>
<li>SARS-CoV-2による肺炎(ただし、酸素吸入を要する患者に限る)</li>
<li>円形脱毛症(ただし、脱毛部位が広範囲に及ぶ難治の場合に限る)</li>
</ul>
<h3 id="禁忌"><a href="#禁忌" class="headerlink" title="禁忌"></a>禁忌</h3><ul>
<li>各適応症共通<ul>
<li>本剤への過敏症の既往歴がある患者</li>
<li>活動性結核の患者</li>
<li>好中球数が500&#x2F;mm3未満の患者</li>
<li>妊婦又は妊娠している可能性のある女性</li>
</ul>
</li>
<li>関節リウマチ、アトピー性皮膚炎、円形脱毛症<ul>
<li>重篤な感染症(敗血症等)の患者</li>
<li>重度の腎機能障害を有する患者(eGFRが30未満)</li>
<li>リンパ球数が500&#x2F;mm3未満の患者<br>-ヘモグロビン値が8g&#x2F;dL未満の患者</li>
</ul>
</li>
<li>SARS-COV-2による肺炎<ul>
<li>透析患者又は末期腎不全(eGFRが15未満)</li>
<li>リンパ球数が200&#x2F;mm3未満の患者</li>
</ul>
</li>
</ul>
<h3 id="COVID-19"><a href="#COVID-19" class="headerlink" title="COVID-19"></a>COVID-19</h3><p>2020年11月、FDAはバリシチニブとレムデシビルの併用療法について、補助酸素、侵襲的機械式人工呼吸、または体外式膜酸素供給（ECMO）を必要とする2歳以上の入院患者におけるCOVID-19の疑いまたは検査で確認されたCOVID-19の治療のための緊急使用許可（EUA）を発行した。</p>
<p>2021年4月23日、日本でSARS-CoV-2による肺炎の治療薬としてバリシチニブが承認された。</p>

      
    </div>
    <footer class="entry-meta entry-footer">
      
      
  <span class="ico-tags"></span>
  <ul class="article-tag-list" itemprop="keywords"><li class="article-tag-list-item"><a class="article-tag-list-link" href="/tags/Chemical/" rel="tag">Chemical</a></li></ul>

      
        
	<section id="comments" class="comment">
	  <div id="disqus_thread">
	  <noscript>Please enable JavaScript to view the <a target="_blank" rel="noopener" href="//disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
	  </div>
	</section>

	<script type="text/javascript">
	var disqus_shortname = '88oio';
	(function(){
	  var dsq = document.createElement('script');
	  dsq.type = 'text/javascript';
	  dsq.async = true;
	  dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js';
	  (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
	}());
	(function(){
	  var dsq = document.createElement('script');
	  dsq.type = 'text/javascript';
	  dsq.async = true;
	  dsq.src = '//' + disqus_shortname + '.disqus.com/count.js';
	  (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
	}());
	</script>



      
    </footer>
    <hr class="entry-footer-hr">
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2023/01/16/2023-01-16-06-06-mercury/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          Mercury ☿
        
      </div>
    </a>
  
  
    <a href="/2022/12/25/2022-12-24-20-19-a-350/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title">Airbus A350 Avionics 🛬</div>
    </a>
  
</nav>

  
</article>

<!-- Table of Contents -->

  
  <aside id="sidebar">
    <div id="toc" class="toc-article">
    <strong class="toc-title">Contents</strong>
    
      <ol class="nav"><li class="nav-item nav-level-3"><a class="nav-link" href="#Mechanism-of-action"><span class="nav-number">1.</span> <span class="nav-text">Mechanism of action</span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#Pharmacokinetics"><span class="nav-number">2.</span> <span class="nav-text">Pharmacokinetics</span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#Side-effects"><span class="nav-number">3.</span> <span class="nav-text">Side effects</span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E5%8A%B9%E8%83%BD"><span class="nav-number">4.</span> <span class="nav-text">効能</span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#%E7%A6%81%E5%BF%8C"><span class="nav-number">5.</span> <span class="nav-text">禁忌</span></a></li><li class="nav-item nav-level-3"><a class="nav-link" href="#COVID-19"><span class="nav-number">6.</span> <span class="nav-text">COVID-19</span></a></li></ol>
    
    </div>
  </aside>
  
</section>
        
      </div>

    </div>
    <!-- <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
    <a href="/categories" class="mobile-nav-link">Categories</a>
  
    <a href="/tags" class="mobile-nav-link">Tags</a>
  
    <a href="/about" class="mobile-nav-link">About</a>
  
</nav> -->
    <footer id="footer" class="site-footer">
  

  <div class="clearfix container">
      <div class="site-info">
	      &copy; 2024 iClass eXpert All Rights Reserved.
        
      </div>
  </div>
</footer>


<!-- min height -->

<script>
    var wrapdiv = document.getElementById("wrap");
    var contentdiv = document.getElementById("content");

    wrapdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";
    contentdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";


    <!-- headerblur min height -->
    
    
</script>
    
<div style="display: none;">
  <script src="https://s11.cnzz.com/z_stat.php?id=1260716016&web_id=1260716016" language="JavaScript"></script>
</div>

<!-- mathjax config similar to math.stackexchange -->

<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    tex2jax: {
      inlineMath: [ ['$','$'], ["\\(","\\)"] ],
      processEscapes: true
    }
  });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
      }
    });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax(), i;
        for(i=0; i < all.length; i += 1) {
            all[i].SourceElement().parentNode.className += ' has-jax';
        }
    });
</script>

<script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>



  
<link rel="stylesheet" href="/fancybox/jquery.fancybox.css">

  
<script src="/fancybox/jquery.fancybox.pack.js"></script>




<script src="/js/script.js"></script>


<script src="/js/bootstrap.js"></script>


<script src="/js/main.js"></script>














  </div>

  <a id="rocket" href="#top" class=""></a>
  <script type="text/javascript" src="/js/totop.js" async=""></script>
</body>
</html>
